
Citius Pharmaceuticals Inc (CTXR)
NASDAQ
Fin d'année 30 Septembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -44.795 | -45.204 | -51.841 | -48.235 | -24.762 | -30.84 | -30.967 | -36.489 |
Return on Equity (%) | -53.651 | -50.336 | -59.573 | -60.458 | -27.7 | -33.48 | -34.583 | -48.553 |
Return on Invested Capital (%) | -51.682 | -55.372 | -59.778 | -43.803 | -28.263 | -33.215 | -37.716 | -50.764 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.197 | 0.824 | 0.117 | 0.089 | 0.439 | 0.237 | 0.143 | -0.155 |
Earnings Per Share | -2.13 | -1.502 | -0.538 | -0.316 | -0.158 | -0.271 | -0.212 | -0.222 |
Cash Per Share | 0.657 | 1.1 | 0.273 | 0.249 | 0.48 | 0.285 | 0.167 | 0.018 |
Working Capital Per Share | 0.196 | 0.824 | 0.115 | 0.178 | 0.472 | 0.274 | 0.18 | -0.119 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -2.13 | -1.502 | -0.538 | -0.316 | -0.158 | -0.267 | -0.201 | -0.215 |
EBITDA Per Share | -2.13 | -1.502 | -0.538 | -0.316 | -0.158 | -0.267 | -0.201 | -0.215 |
Free Cash Flow Per Share | -2.13 | -1.502 | -0.538 | -0.316 | -0.158 | -0.271 | -0.212 | -0.195 |
Fin d'année 30 Septembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 4,88M | 8,35M | 28,93M | 55,58M | 145,98M | N/A | N/A | N/A |
Fin d'année 30 Septembre 2024 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 146,21M | N/A | 158,86M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 15,3M |
Ratio cours/bénéfice | -0,38 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 4,68 |
Ratio prix/valeur comptable | 0,21 |
Rendement de dividende | - |
Actions en circulation | 8,59M |
Volume moyen (1 semaine) | 80,01k |
Volume moyen (1 mois) | 179,45k |
Variation sur 52 semaines | -90,00% |
Plus haut sur 52 semaines | 26,75 |
Plus bas sur 52 semaines | 1,47 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales